Organogenesis Holdings Inc. to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
Rhea-AI Summary
Organogenesis Holdings Inc. (Nasdaq: ORGO) has announced its participation in the Morgan Stanley 20th Annual Global Healthcare Conference, taking place from September 12-14, 2022, at the Sheraton New York Times Square Hotel. The management will engage in a fireside chat on September 13 at 11:45 a.m. Eastern Time. A live audio webcast of the presentation will be available on the company’s website, with a replay accessible for 30 days post-conference. Organogenesis specializes in regenerative medicine, focusing on advanced wound care and surgical solutions.
Positive
- None.
Negative
- None.
News Market Reaction – ORGO
On the day this news was published, ORGO declined 3.03%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
CANTON, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that company management will participate in the Morgan Stanley 20th Annual Global Healthcare Conference, which is being held at the Sheraton New York Times Square Hotel in New York, NY from September 12th-14th. Management will host a fireside chat on Tuesday, September 13th at 11:45 a.m. Eastern Time.
A live audio webcast of the conference presentation will be accessible by visiting the “Upcoming Events” section on the “Investor Relations” page of Organogenesis’s website www.organogenesis.com. An archive of the webcast will be available for replay following the conference for approximately 30 days.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics. Organogenesis’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs. For more information, visit www.organogenesis.com.
FAQ
When will Organogenesis participate in the Morgan Stanley Healthcare Conference?
What time is the fireside chat for Organogenesis at the conference?
How can I access the live webcast of the Organogenesis conference presentation?
Will there be a replay available for the Organogenesis conference presentation?
What does Organogenesis focus on in their business?
